Aveanna Healthcare Holdings Inc. (AVAH) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Aveanna Healthcare Holdings Inc. (AVAH) Healthcare & Pipeline Overview

Aveanna Healthcare Holdings Inc. is a diversified home care platform providing private duty nursing, adult home health and hospice, pediatric therapy, and enteral nutrition services across the United States. The company's focus on in-home care aims to reduce reliance on expensive institutional settings, positioning it within the growing home healthcare market.

What Is the Investment Thesis for AVAH?

Aveanna Healthcare Holdings Inc. presents a notable research candidate within the growing home healthcare market. With a market capitalization of $2.84B and a P/E ratio of 5.7, the company demonstrates strong profitability with a 9.2% profit margin and a 33.1% gross margin. Key value drivers include the increasing demand for home-based care, driven by an aging population and a preference for in-home services. Growth catalysts include expanding service offerings within existing markets and strategic acquisitions to broaden geographic reach. However, investors may want to evaluate potential risks such as regulatory changes, reimbursement pressures, and competition within the fragmented home healthcare industry. The company's beta of 2.08 indicates higher volatility compared to the market.

Based on FMP financials and quantitative analysis

AVAH Key Highlights

Market capitalization of $2.84B, reflecting substantial investor interest in the home healthcare sector.

• P/E ratio of 5.7, suggesting potential undervaluation compared to industry peers.
• Profit margin of 9.2%, indicating efficient operations and cost management.
• Gross margin of 33.1%, demonstrating the company's ability to maintain profitability across its service offerings.
• Beta of 2.08, signaling higher volatility compared to the broader market, potentially offering higher returns but also increased risk.

Who Are AVAH's Competitors?

AVAH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AVAH's Key Strengths?

Diversified service offerings across the home care continuum.

• Established presence in multiple geographic markets.
• Strong focus on medically complex patients.
• Experienced management team.

What Are AVAH's Weaknesses?

Exposure to reimbursement pressures from government and private payers.

• High reliance on skilled nursing and therapy professionals.
• Potential for regulatory scrutiny and compliance challenges.
• Sensitivity to changes in healthcare policy.

What Could Drive AVAH Stock Higher?

Increasing demand for home healthcare services due to the aging population.

• Expansion of telehealth and remote monitoring capabilities.
• Potential acquisitions of smaller regional home care providers.
• Development of specialized care programs for chronic conditions.

What Are the Key Risks for AVAH?

Insider selling — insiders were net sellers of roughly $215.6M recently.

• Changes in reimbursement rates and policies from government and private payers.
• Labor shortages and rising wage costs for skilled nursing and therapy professionals.
• Increased competition from other home care providers.
• Regulatory scrutiny and compliance challenges related to healthcare operations.

What Are the Growth Opportunities for AVAH?

• Expansion of Pediatric Therapy Services: Aveanna can capitalize on the growing demand for pediatric therapy services, including physical, occupational, and speech therapy. The market for pediatric therapy is estimated to reach $40 billion by 2028, driven by increasing awareness of developmental disorders and the benefits of early intervention. Aveanna's existing infrastructure and expertise in pediatric care provide a strong foundation for expanding its therapy services both in-clinic and in-home.
• Strategic Acquisitions: Aveanna can pursue strategic acquisitions to expand its geographic footprint and service offerings. The home healthcare market remains fragmented, presenting opportunities to acquire smaller regional players and integrate them into Aveanna's platform. Targeted acquisitions can provide access to new markets, specialized services, and skilled personnel, accelerating Aveanna's growth trajectory. These acquisitions could be funded through a combination of cash and debt.
• Increased Focus on Home Health and Hospice: The aging population and increasing preference for in-home care are driving demand for home health and hospice services. Aveanna can expand its HHH segment by increasing its presence in underserved markets and enhancing its service offerings to include specialized care programs for chronic conditions. The market for home health and hospice is projected to reach $300 billion by 2030, presenting a significant growth opportunity for Aveanna.
• Leveraging Technology for Enhanced Care Delivery: Aveanna can invest in technology solutions to improve care coordination, enhance patient engagement, and streamline operations. Telehealth platforms, remote monitoring devices, and data analytics tools can enable Aveanna to deliver more efficient and effective care, while also reducing costs. The adoption of technology can also improve patient outcomes and satisfaction, further strengthening Aveanna's competitive advantage.
• Expansion of Enteral Nutrition Services: Aveanna's Medical Solutions segment, which provides enteral nutrition supplies, represents a significant growth opportunity. The market for enteral nutrition is growing due to the increasing prevalence of chronic diseases and the rising number of patients requiring nutritional support. Aveanna can expand its enteral nutrition business by offering a wider range of products, improving its distribution network, and enhancing its customer service capabilities. This expansion could include partnerships with hospitals and long-term care facilities.

What Are AVAH's Competitive Advantages?

• Diversified service offerings across the continuum of home care.
• Established relationships with payers and referral sources.
• Extensive network of skilled nurses, therapists, and other healthcare professionals.
• Focus on medically complex patients, creating a niche market with higher barriers to entry.

What Does AVAH Do?

Aveanna Healthcare Holdings Inc., established in 2016 and headquartered in Atlanta, Georgia, operates as a diversified home care platform. The company was founded with the mission of providing patient-centered care in the comfort of patients' homes, thereby minimizing the need for costly hospital stays and other institutional settings. Aveanna has grown to become a significant provider in the home care industry, offering a range of services including private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services. These services are delivered through three primary segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment focuses on in-home skilled nursing for medically fragile children, nursing services in school settings, pediatric day healthcare centers, employer of record support, personal care services, and in-clinic and home-based pediatric therapy. The HHH segment provides in-home skilled nursing, physical, occupational, and speech therapy, medical social and aide services, and hospice care. The MS segment offers enteral nutrition supplies and other products to both adults and children. Aveanna's comprehensive service offerings and focus on home-based care position it as a key player in the evolving healthcare landscape.

What Products and Services Does AVAH Offer?

• Provides private duty nursing (PDN) services to medically fragile children.
• Offers nursing services in school settings, accompanying patients to school.
• Operates pediatric day healthcare centers.
• Provides employer of record support and personal care services.
• Delivers in-clinic and home-based pediatric therapy services (physical, occupational, speech).
• Offers home health services, including skilled nursing, therapy, and aide services.
• Provides hospice services for patients with life-limiting illnesses.
• Supplies enteral nutrition products to adults and children.

How Does AVAH Make Money?

• Generates revenue through providing skilled nursing and therapy services in patients' homes and other settings.
• Earns revenue from the sale of enteral nutrition supplies and related products.
• Contracts with insurance companies, government payers (e.g., Medicaid), and private individuals for service reimbursement.
• Operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS).

What Industry Does AVAH Operate In?

Aveanna Healthcare Holdings Inc. operates within the expanding home healthcare industry, driven by an aging population and a growing preference for in-home care services. The market is characterized by increasing demand for cost-effective and patient-centered care models. While the industry is fragmented, Aveanna competes with both national and regional players, including traditional home health agencies and specialized care providers. The company's diversified service offerings and focus on medically complex patients provide a competitive edge in this dynamic landscape. The home healthcare market is projected to continue growing, fueled by technological advancements and evolving reimbursement models.

Who Are AVAH's Key Customers?

• Medically fragile children requiring skilled nursing care.
• Adults needing home health services, including skilled nursing and therapy.
• Patients with life-limiting illnesses requiring hospice care.
• Individuals requiring enteral nutrition supplies and related products.

Company Profile

Aveanna Healthcare Holdings Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Atlanta, US. The company is led by CEO Jeffrey S. Shaner. AVAH has traded publicly since 2021.

Aveanna Healthcare Holdings Inc. Financial Trajectory

Aveanna Healthcare Holdings Inc. (AVAH) reported $670.5M in revenue for Q3 2026, reflecting 3.5% growth compared to the prior quarter. The company recorded net income of $40.3M, with diluted EPS of $0.18. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, AVAH averaged $0.32 in diluted EPS.

How Aveanna Healthcare Holdings Inc. Is Valued

Aveanna Healthcare Holdings Inc. carries a market capitalization of $2.84B, placing it in the mid-cap category. Relative to its peer group, AVAH's quantitative score of 69/100 is roughly in line with the peer average of 71/100.

Return on equity for Aveanna Healthcare Holdings Inc. stands at 241.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 12.9%, showing how much profit it generates from its asset base. AVAH trades at a trailing price-to-earnings ratio of 5.65, below the Healthcare sector average of ~23x. Its free cash flow yield is 9.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.47 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 17.7%, the inverse of the P/E and a quick read on earnings relative to price.

Aveanna Healthcare Holdings Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.91 places it in the grey zone, a middle ground that warrants monitoring.

Wall Street analysts project Aveanna Healthcare Holdings Inc. revenue of about $2.63B for fiscal 2027, with EPS near $0.71. The estimate reflects 7 contributing analysts.

Over the past six months, Aveanna Healthcare Holdings Inc. insiders filed 22 SEC Form 4 transactions — 22 sales and 0 purchases. On net that is roughly 31.3M shares disposed (about $215.6M), a signal worth weighing alongside the fundamentals.

AVAH Financials

AVAH Latest News

AVAH Analyst Consensus

AVAH MoonshotScore

Common Questions About AVAH (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources